These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12843927)

  • 1. [Reversible adrenal insufficiency after interferon-alpha therapy for chronic hepatitis C].
    Lévy S; Abdelli N; Diebold MD; Gross A; Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):563-4. PubMed ID: 12843927
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
    Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
    Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anosmia secondary to treatment with interferon in a patient with chronic hepatitis C].
    Fernández Fernández FJ; Castiella Eguzkiza A; Tejada Calabia AM; García Bengoechea M
    Gastroenterol Hepatol; 2000 Dec; 23(10):499-500. PubMed ID: 11149229
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.
    Fukuyama S; Kajiwara E; Suzuki N; Miyazaki N; Sadoshima S; Onoyama K
    Am J Gastroenterol; 2000 Jan; 95(1):310-2. PubMed ID: 10638610
    [No Abstract]   [Full Text] [Related]  

  • 7. A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.
    Fisher ME; Rossini M; Simmons E; Harris RC; Moeckel G; Zent R
    Am J Kidney Dis; 2004 Sep; 44(3):567-73. PubMed ID: 15332232
    [No Abstract]   [Full Text] [Related]  

  • 8. Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.
    Chatterjee S
    J Assoc Physicians India; 2004 Jun; 52():514. PubMed ID: 15645973
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon-induced hepatic failure in a patient with hepatitis C.
    Lock G; Reng CM; Graeb C; Anthuber M; Wiedmann KH
    Am J Gastroenterol; 1999 Sep; 94(9):2570-1. PubMed ID: 10484034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Painless subacute thyroiditis with negative antithyroid antibodies during alpha interferon treatment in chronic hepatitis C].
    Mauri S; Puig J; Martínez-Riquelme A
    Med Clin (Barc); 1999 Nov; 113(16):636. PubMed ID: 10609261
    [No Abstract]   [Full Text] [Related]  

  • 12. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon-induced haemolytic anaemia in hepatitis C.
    Al-Ansari M; Weilert F; Dickson G
    N Z Med J; 2008 Jul; 121(1278):78-81. PubMed ID: 18670477
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.
    Demirturk N; Cevik F; Demirdal T; Aykin N; Aslan V
    Platelets; 2006 Aug; 17(5):340-3. PubMed ID: 16928608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome due to interferon-alpha.
    LaRochelle JS; Karp BI
    Mov Disord; 2004 Jun; 19(6):730-1. PubMed ID: 15197722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
    Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S
    Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 18. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
    Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
    Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
    [No Abstract]   [Full Text] [Related]  

  • 19. Threshold for neutropenia in the adjustment of interferon treatment in HCV infection.
    Renou C; Harafa A; Cummins C; Muller P; Dematteï C; Jouve E; Bertrand JJ; Halfon P
    Hepatology; 2003 Apr; 37(4):949-50; author reply 950. PubMed ID: 12668993
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C.
    Mundt AP; Sarkar R; Winter C; Schaefer M; Ströhle A
    Psychosomatics; 2007; 48(1):86-7. PubMed ID: 17209157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.